Hermetica Superfood Encyclopedia
The Short Answer
Fetau resin oil contains calophyllolide, inophyllum C and P, tamanolides, and high concentrations of phenolics and flavonoids (TPC up to 289.12 mg GAE/g in leaf extracts) that exert antioxidant, anti-inflammatory, and antimicrobial effects through free-radical scavenging, COX pathway inhibition, and disruption of bacterial cell integrity. In vitro studies demonstrate potent DPPH antioxidant activity (IC50 as low as 0.004 mg/mL in bark methanolic extract) and selective cytotoxicity against lung cancer cell lines comparable to doxorubicin (IC50 0.90 ± 0.12 µg/mL), though no human clinical trials have yet confirmed these effects in vivo.
CategoryOther
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordfetau oil benefits
Fetau — botanical close-up
Health Benefits
**Antioxidant Protection**
Phenolics and flavonoids in fetau leaf extracts—reaching TPC of 289.12 mg GAE/g and TFC of 410.4 mg QE/g with 80% methanol extraction—quench reactive oxygen species via DPPH scavenging at IC50 values as low as 0.004 mg/mL, suggesting robust free-radical neutralization capacity.
**Antimicrobial Activity**
Non-polar hexane bark extracts produce inhibition zones of 17.96 ± 0.00 mm against Staphylococcus aureus and MIC values below 0.098 mg/mL against Bacillus cereus across 11 of 15 tested extracts, attributable to lipophilic terpenoids and saponins disrupting microbial membranes.
**Anti-Inflammatory Effects**
Calophyllolide, a coumarin-class compound concentrated in the resin oil, modulates inflammatory cascades, likely through inhibition of prostaglandin synthesis and NF-κB signaling, consistent with its traditional application to wounds and skin irritation.
**Selective Anticancer Potential**
Inophyllum C and P, chromene-class compounds in the resin, exhibit selective in vitro cytotoxicity against lung cancer cell lines, with efficacy benchmarked against doxorubicin and ellipticine, while in silico ADME profiling of key flower compounds suggests favorable oral bioavailability and minimal off-target toxicity.
**Antiviral and Anti-HIV Activity**
Inophyllum C has been identified in the literature as exhibiting anti-HIV and broader antiviral properties in cell-based assays, likely through inhibition of viral reverse transcriptase or entry mechanisms, though mechanistic details remain under investigation.
**Wound Healing and Skin Repair**
Traditional topical use of fetau resin oil as an antiseptic aligns with its demonstrated antimicrobial phenolic content and the emollient properties of its fatty acid profile (including palmitic acid), which together support epidermal barrier restoration and infection prevention.
**Antifilarial and Antiparasitic Properties**
Broader phytochemical screening has identified antifilarial, larvicidal, and antiplatelet activities in various plant-part extracts, suggesting multi-target bioactivity relevant to tropical parasitic disease management, though these remain at early preclinical stages.
Origin & History
Natural habitat
Calophyllum inophyllum is a tropical evergreen tree native to coastal regions of South and Southeast Asia, East Africa, and across the Pacific Islands, including Tonga, Samoa, Fiji, and Hawaii, where it thrives in sandy, well-drained soils near shorelines and tolerates salt spray. The tree grows up to 25 meters tall and is cultivated throughout the Indo-Pacific for its dense, glossy canopy, fragrant white flowers, and round green fruits that yield a thick, dark resin oil. In Polynesian cultures—particularly Tongan and Samoan—the tree is called fetau, while in French Polynesia and the broader ethnobotanical literature it is synonymous with tamanu, reflecting its pan-Pacific cultural and economic significance.
“Fetau holds deep cultural significance across Polynesia, where Tongan and Samoan communities have harvested the tree's resin oil for centuries as a primary topical remedy for wounds, skin infections, skin diseases, and as a general antiseptic, often applying the dark, viscous oil directly to affected areas as part of traditional healing ceremonies. In French Polynesia the same oil is celebrated as tamanu, and its use for dermatological conditions—including scars, eczema, psoriasis, and rheumatic pain—has been documented since early European contact with Pacific Island communities in the 18th century. The tree's roots have also been used in traditional agroforestry for soil restoration and erosion control in coastal planting systems, reflecting an integrated cultural understanding of the plant's ecological and medicinal value. Historical records and ethnobotanical surveys confirm that the preparation method across Pacific Island cultures has remained consistent—manual expression or low-heat rendering of the resin from sun-dried seeds and bark—a process now being replicated in modern cold-press commercial tamanu oil production.”Traditional Medicine
Scientific Research
The current evidence base for fetau (Calophyllum inophyllum) consists almost entirely of in vitro phytochemical and cell-line studies, with no published randomized controlled trials or prospective human studies identified as of the available literature. Key in vitro findings include DPPH IC50 values of 0.004 mg/mL for bark methanolic extracts and 0.054 µg/mL for optimized leaf extracts, alongside antibacterial inhibition zones up to 17.96 mm against S. aureus and cytotoxicity benchmarked against doxorubicin (IC50 0.90 ± 0.12 µg/mL on lung cancer lines). Regional phytochemical variation studies from Fiji and other Pacific sites have characterized resin oil composition, identifying calophyllolide, inophyllums C/P, and tamanolides E1/E2, and in silico ADME modelling has provided preliminary pharmacokinetic support for oral bioavailability. The overall evidence quality is preclinical; results are promising but cannot yet be extrapolated to human therapeutic outcomes without adequately powered clinical trials.
Preparation & Dosage
Traditional preparation
**Traditional Resin Oil (Tamanu/Fetau Oil)**
Applied topically to skin wounds, burns, and infections; no standardized dose established; typically used undiluted or diluted 1:1 with a carrier oil for sensitive skin.
**Methanolic Leaf Extract**
12 mg GAE/g) and TFC (410
Optimal extraction uses 80% methanol at 30°C for 48 hours, yielding 2.41–2.58% extract with highest TPC (289..4 mg QE/g); no human oral dose established.
**Hexane Bark Extract**
27 mg EE/g) and antibacterial activity; used in antimicrobial research contexts only; no clinical dose defined
Preferred solvent for maximizing saponin (TSC up to 4.96 ± 2..
**Ethyl Acetate and Methanol Multi-Part Extracts**
Yields range from 1.64% to 58.89% depending on plant part and solvent polarity; flowers, fruits, leaves, twigs, and bark all used as starting material in research protocols.
**Standardization**
No commercial standardization percentages for calophyllolide or inophyllums have been formally established; regional variation in resin composition (e.g., higher inophyllum C in Fiji-sourced material) underscores the need for batch-specific quality control.
**Timing and Administration**
Traditional use is topical and continuous for wound or skin conditions; oral administration is not defined in clinical practice and carries uncharacterized risk at this stage of research.
Nutritional Profile
Fetau is not consumed as a food source and lacks a conventional macronutrient or micronutrient profile; its nutritional relevance is confined to its phytochemical composition. The resin oil is rich in fatty acids, prominently palmitic acid (a saturated C16 fatty acid) alongside unsaturated fatty acids, which confer emollient and skin-barrier properties. Phytochemical constituents quantified in plant parts include alkaloids (11.51%), tannins (7.68%), triterpenoids (2.48%), polyphenols (2.53%), flavonoids (2.37%), and saponins (2.16%) in the methanolic leaf fraction, as well as volatile terpenoids such as α-copaene, α-muurolene, β-muurolene, γ-cadinene, δ-cadinene, and the diterpene alcohol phytol. Specific bioactive molecules include calophyllolide, inophyllum C and P, tamanolide E1 and E2, eugenol, caryophyllene oxide, and the coumarin-derived compound calanolide Gut 70; bioavailability of key molecules is predicted to be favorable via in silico ADME modelling, with high gastrointestinal absorption and blood–brain barrier permeability for eugenol and caryophyllene oxide, though human pharmacokinetic data remain absent.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves hydrogen atom transfer and single-electron transfer from phenolic hydroxyl groups of flavonoids and polyphenols—present at concentrations up to 2.53% polyphenols and 2.37% flavonoids in the methanolic leaf fraction—to neutralize DPPH, superoxide, and hydroxyl radicals, with activity strongly correlating to total phenolic content. Calophyllolide, a tetracyclic coumarin found in the resin oil, is proposed to inhibit arachidonic acid metabolism and NF-κB transcriptional activation, reducing pro-inflammatory cytokine expression at the gene level. Inophyllum C and P, chromene-type compounds enriched in the resin (with regional variation; Fijian samples show higher inophyllum C), likely interact with topoisomerase enzymes or viral reverse transcriptase to produce cytotoxic and antiviral effects, respectively. In silico ADME analysis of eugenol and caryophyllene oxide—volatile compounds identified in floral extracts—confirms compliance with Lipinski's Rule of Five, high gastrointestinal absorption, blood–brain barrier permeability, and minimal CYP450 inhibition, indicating these molecules may also contribute to systemic and potentially central nervous system bioactivity following oral administration.
Clinical Evidence
No human clinical trials with defined sample sizes, randomization, or quantified effect sizes have been conducted on fetau or its isolated bioactives in therapeutic contexts as reported in the available literature. The anticancer data derive exclusively from in vitro cytotoxicity assays comparing fetau extracts against established chemotherapy standards (doxorubicin, ellipticine, tamoxifen) on lung and other cancer cell lines, a study design that, while informative for mechanistic hypothesis generation, has low predictive validity for human outcomes. Antimicrobial, antioxidant, and anti-inflammatory endpoints have similarly been evaluated only in microbiological and biochemical assay systems. Confidence in clinical benefit is therefore low, and all reported outcomes should be classified as hypothesis-generating preclinical signals pending future Phase I/II human trials.
Safety & Interactions
Comprehensive human toxicity data for fetau extracts or resin oil are not yet available, and no maximum safe oral dose has been established; the existing safety inference is derived from its long history of topical traditional use in Pacific Island communities without documented systemic adverse events. In vitro cytotoxicity studies suggest selective activity against cancer cell lines with relative sparing of normal cells, which is a preliminary favorable safety signal but is insufficient to establish a human therapeutic index. In silico CYP450 inhibition modelling for floral compounds (eugenol, caryophyllene oxide) predicts minimal drug–drug interaction risk at this enzyme system, though bark and resin oil compounds have not been similarly characterized, leaving interaction profiles with anticoagulants, immunosuppressants, or cytotoxic drugs undefined. Topical application is generally considered low-risk based on traditional use, but individuals with tree nut or latex sensitivities should exercise caution; use during pregnancy and lactation is not recommended due to the complete absence of reproductive safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Calophyllum inophyllumTamanuKamaniDiloAlexandrian laurelPunnaiBeauty leaf
Frequently Asked Questions
What is fetau oil and how is it different from tamanu oil?
Fetau and tamanu refer to the same plant species, Calophyllum inophyllum, with 'fetau' being the Tongan and Samoan name and 'tamanu' the term used primarily in French Polynesia and the broader cosmetic industry. Both names describe the dark, viscous resin oil extracted from the seeds and bark of the tree, which contains the same bioactive compounds—calophyllolide, inophyllum C and P, tamanolides, and fatty acids—and is used identically for topical wound healing, antiseptic care, and skin repair.
What does the research say about fetau oil for skin healing?
Current research is preclinical, with no human clinical trials published, but in vitro studies confirm that fetau extracts contain high levels of phenolics (TPC up to 289.12 mg GAE/g in leaf extracts) and demonstrate potent antimicrobial activity, including inhibition zones of nearly 18 mm against Staphylococcus aureus. The resin oil's fatty acid profile—including palmitic acid—alongside calophyllolide's anti-inflammatory properties provides a plausible mechanistic basis for the traditional use of fetau oil in wound healing, scar reduction, and skin infection management, though controlled human trials are needed to confirm efficacy.
Is fetau oil safe to use on skin?
Topical use of fetau (tamanu) resin oil has a multi-century history in Pacific Island communities without documented widespread adverse effects, suggesting a reasonable safety profile for external application. However, individuals with known sensitivities to tree nuts or latex should patch-test first, as cross-reactivity is theoretically possible; no formal toxicological studies or standardized safety assessments have been published for topical or oral fetau preparations, so caution is warranted for vulnerable populations including pregnant or breastfeeding women.
Does fetau have anticancer properties?
In vitro studies have demonstrated selective cytotoxicity of fetau extracts against lung cancer cell lines, with activity benchmarked against doxorubicin (IC50 0.90 ± 0.12 µg/mL) and attributed primarily to chromene-class compounds inophyllum C and P. These findings are exclusively from cell-based laboratory experiments and have not been replicated in animal models or human trials, meaning fetau cannot be considered an evidence-based anticancer treatment at this time; the data represent early-stage hypothesis generation only.
What is the best way to use fetau or tamanu oil?
The most established and traditional method is topical application of the cold-pressed resin oil directly to affected skin areas—wounds, scars, eczema, or infections—either undiluted or diluted 1:1 with a carrier oil such as coconut oil to improve spreadability and dermal penetration. No standardized oral dose exists, and internal use is not recommended given the absence of human pharmacokinetic or safety data; commercially available tamanu oil should ideally be cold-pressed, unrefined, and traceable to a specific regional source, as phytochemical composition (including inophyllum C content) varies geographically.
What is the antimicrobial potency of fetau bark extract compared to common skin pathogens?
Fetau bark extracts in hexane form demonstrate significant antimicrobial activity, producing inhibition zones of 17 mm or greater against various microorganisms, making it potentially effective against common skin bacteria and fungi. This antimicrobial capacity supports its traditional use in treating infected wounds and skin conditions, though clinical studies comparing it directly to conventional antimicrobials remain limited. The non-polar extraction method appears to concentrate the bioactive compounds responsible for this activity.
How do fetau leaf extracts compare in antioxidant strength to standard antioxidant markers?
Fetau leaf extracts show exceptionally high antioxidant potential, with DPPH free-radical scavenging IC50 values as low as 0.004 mg/mL, indicating potent free-radical neutralization at very low concentrations. When extracted with 80% methanol, the extracts achieve total phenolic content of 289.12 mg GAE/g and total flavonoid content of 410.4 mg QE/g, demonstrating substantial polyphenol concentration. These values suggest fetau leaf extracts may rival or exceed the antioxidant capacity of commonly recognized antioxidant supplements.
Which part of the Calophyllum inophyllum plant (fetau) contains the most bioactive compounds?
Both fetau bark and leaves contain significant bioactive compounds, but they differ in extraction profiles: leaf extracts yield higher polyphenolic and flavonoid concentrations (particularly with methanol extraction), while bark extracts concentrate antimicrobial compounds in non-polar (hexane) forms. The optimal plant part depends on the intended benefit—leaves for antioxidant protection and bark for antimicrobial applications. Traditional preparation methods and extraction solvents substantially influence which compounds are bioavailable from each plant part.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w fetau-calophyllum-inophyllum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
